Dr. Geeta Vemuganti , senior faculty in the School of Medical Sciences at University of Hyderabad (UoH) is being honoured as Silver Fellow in the ARVO Fellow Club 2019. The honour is given to a member based on for his/her contributions over the years to Association of Research in Vision and Ophthalmology (ARVO, USA) evaluated objectively by the committee . The medal will be presented to Dr Vemuganti at the ARVO meeting Keynote Session in Vancouver, BC, 28th April- 2nd May 2019.
As a Fellow of ARVO, Dr. Vemuganti will serve as a role model and mentor for individuals pursuing careers in vision and ophthalmology research and to further ARVO’s vision “.to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders,” which includes advancing basic and clinical knowledge and serving as the leading international forum for vision research and the primary advocate for vision science worldwide.
Dr Vemuganti is a member of ARVO since 1999 and has served in various capacities and members of various committees like Program committee, Awards committee, Global Member Committee and currently is a member of Ethics and Regulations in Human Research Committee.
The Association for Research in Vision and Ophthalmology, Inc. (ARVO) was founded in 1928 in Washington, DC by a group of 73 ophthalmologists. ARVO was originally named the Association for Research in Ophthalmology (ARO), but the word “vision” was added in 1970 to better reflect the scientific profile of its 12000 members residing in over 75 countries outside the U.S. The annual meetings of ARVO are held across US and Canada. The membership is multidisciplinary and consists of both clinical and basic researchers. About 29% are MDs, 27% are PhDs, and 35% are optometrists, osteopaths and veterinarians. ARVO through its International Chapter Affiliates in various countries also connects the global community of eye and vision scientists and advances research worldwide into understanding the visual system and preventing, treating and curing its disorders.